(PRWEB) March 7, 2011
onPoint Oncology LLC., a unique healthcare management, data analysis, reimbursement, and direct-to-provider marketing company based in Hudson, Ohio, recently added another experienced professional to their executive team with the addition of Mr. Kerry Bradley as Principal, responsible for Payer-Provider Relations. Mr. Bradley brings an extensive background in the business of oncology including a broad range of experience working with commercial payers, physician practices, pharmaceutical manufacturers and other industry leaders. As a participant on multiple industry advisory panels and associations, he brings valuable insight to the trends affecting oncology today.
A healthcare management veteran, prior to joining onPoint Oncology, Mr. Bradley spent fourteen years with Aventis Pharmaceuticals in leadership positions of increasing responsibility. This included eight years in the oncology business unit in a number of roles including Brand Director and Head of National Accounts where Mr. Bradley was responsible for managing Aventis Oncology’s relationship with many of its key stakeholders. He created and led the team responsible for contract development, management and pricing strategy, marketing, promotional and educational activities for Taxotere®(docetaxel) and Anzemet® (dolasetron).
In 2004, Mr. Bradley became one of the founders and Principals of ICORE Healthcare. ICORE Healthcare was the first healthcare management organization of its kind to successfully help payers address the challenges of managing the explosive growth of high cost injectable drugs in multiple therapeutic categories, with pioneering, cost effective solutions. As Vice President of Oncology Initiatives Mr. Bradley’s latest role at ICORE was developing an innovative, collaborative approach with practicing oncologists to make cancer care more efficient. Other healthcare management responsibilities of note included pharmaceutical manufacturer consulting services and strategy development, and leading ICORE’s Marketing and Communications team.
Because he strongly believes physician collaboration is the key to any successful oncology management program, Mr. Bradley will work with the providers, payers, and pharmaceutical companies to find mutually beneficial solutions for all stakeholders. As the newest Principal, Mr. Bradley brings to onPoint a vast depth and breadth of healthcare management and oncology business expertise that will provide current and future clients with professional, innovative solutions to the challenges faced in their daily business and in the cancer space today.